Company Filing History:
Years Active: 2005-2019
Title: Peter T W Cheng: A Pioneer in Pharmaceutical Innovation
Introduction:
Peter T W Cheng is a renowned inventor in the field of pharmaceuticals, with his expertise and commitment to innovation making him a respected figure in the industry. Based in Princeton, NJ (US), Cheng has obtained an impressive number of 19 patents throughout his career. His dedication to developing novel compounds has led to significant advancements in G protein-coupled receptor (GPCR) modulation, particularly with respect to the GPR120 receptor. Let's delve into Cheng's latest patents, career highlights, collaborations, and his invaluable contributions to the field.
Latest Patents:
Cheng's recent patents revolve around the creation of compounds that function as GPR120 modulators, holding potential as medicinal treatments. One of his latest breakthroughs lies in the development of phenyl-(aza)cycloalkyl carboxylic acid GPR120 modulators. These compounds, described by the patent formula (I), have demonstrated great promise as effective medicaments. Cheng's inventive approach has paved the way for further exploration and development in the field.
Another noteworthy contribution is Cheng's work on cyclobutane-containing carboxylic acid GPR120 modulators. Utilizing compounds of formula (I), Cheng has unlocked new possibilities in GPCR modulation as potential therapeutic agents for various conditions. These patents reflect Cheng's commitment to expanding our understanding of GPR120 function and advancing drug discovery.
Career Highlights:
Cheng's affiliation with Bristol-Myers Squibb Company has been instrumental in his career progression and the advancement of his innovative research. As a leading pharmaceutical company, Bristol-Myers Squibb provides resources and support for Cheng's groundbreaking work in GPCR modulation. Collaborating with esteemed colleagues, Cheng has consistently surpassed industry standards in the pursuit of transformative pharmaceutical solutions.
Collaborations:
Collaboration plays a critical role in the field of innovation, and Cheng's work is no exception. Notably, he has collaborated with Sean Chen and Yan Shi, who are equally esteemed researchers in their own right. Collaborative efforts such as these enable the exchange of ideas, pooling of expertise, and ultimately lead to remarkable breakthroughs. Cheng's collaborations have undoubtedly provided a stimulating environment for fostering innovative solutions to complex medical challenges.
Conclusion:
Peter T W Cheng's contributions to the field of pharmaceutical innovation, particularly in GPCR modulation, are both significant and inspiring. With a remarkable total of 19 patents, including his recent achievements in developing GPR120 modulators, Cheng has solidified his position as a pioneer in the industry. Through his association with Bristol-Myers Squibb Company and collaborations with distinguished colleagues, Cheng has set an example for aspiring inventors and been instrumental in pushing the boundaries of pharmaceutical innovation. His dedication and ongoing contributions continue to shape the landscape of medical treatments and offer hope for patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.